Valluvan Jeevanandam to Anticoagulants
This is a "connection" page, showing publications Valluvan Jeevanandam has written about Anticoagulants.
Connection Strength
0.389
-
Increased Risk of Bleeding in Left Ventricular Assist Device Patients Treated with Enoxaparin as Bridge to Therapeutic International Normalized Ratio. ASAIO J. 2018 Mar/Apr; 64(2):140-146.
Score: 0.126
-
Quality of Anticoagulation With Phenprocoumon and Warfarin in Left Ventricular Assist Device Patients: A Multicenter Study. ASAIO J. 2023 06 01; 69(6):595-601.
Score: 0.044
-
Surgical device exchange provides improved clinical outcomes compared to medical therapy in treating continuous-flow left ventricular assist device thrombosis. Artif Organs. 2020 Apr; 44(4):367-374.
Score: 0.036
-
Laparoscopic procedures in patients with cardiac ventricular assist devices. Surg Endosc. 2019 07; 33(7):2181-2186.
Score: 0.033
-
Omega-3 Therapy Is Associated With Reduced Gastrointestinal Bleeding in Patients With Continuous-Flow Left Ventricular Assist Device. Circ Heart Fail. 2018 10; 11(10):e005082.
Score: 0.033
-
HVAD: The ENDURANCE Supplemental Trial. JACC Heart Fail. 2018 09; 6(9):792-802.
Score: 0.032
-
Long-Acting Octreotide Reduces the Recurrence of Gastrointestinal Bleeding in Patients With a Continuous-Flow Left Ventricular Assist Device. J Card Fail. 2018 Apr; 24(4):249-254.
Score: 0.031
-
Intravenous vitamin K1 prior to orthotopic heart transplantation: effects in vivo and in vitro. Acta Anaesthesiol Scand. 1997 Jan; 41(1 Pt 1):78-83.
Score: 0.029
-
Gastrointestinal bleeding in recipients of the HeartWare Ventricular Assist System. JACC Heart Fail. 2015 Apr; 3(4):303-13.
Score: 0.026